Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 100

1.

Type 1 diabetes is associated with an increase in cholesterol absorption markers but a decrease in cholesterol synthesis markers in a young adult population.

Semova I, Levenson AE, Krawczyk J, Bullock K, Williams KA, Wadwa RP, Shah AS, Khoury PR, Kimball TR, Urbina EM, de Ferranti SD, Bishop FK, Maahs DM, Dolan LM, Clish CB, Biddinger SB.

J Clin Lipidol. 2019 Sep 25. pii: S1933-2874(19)30280-6. doi: 10.1016/j.jacl.2019.09.008. [Epub ahead of print]

PMID:
31706902
2.

Assessing Health-Related Quality of Life in Children and Adolescents with Diabetes: Development and Psychometrics of the Type 1 Diabetes and Life (T1DAL) Measures.

Hilliard ME, Minard CG, Marrero DG, de Wit M, Thompson D, DuBose SN, Verdejo A, Monzavi R, Wadwa RP, Jaser SS, Anderson BJ.

J Pediatr Psychol. 2019 Oct 29. pii: jsz083. doi: 10.1093/jpepsy/jsz083. [Epub ahead of print]

PMID:
31665389
3.

Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes.

Brown SA, Kovatchev BP, Raghinaru D, Lum JW, Buckingham BA, Kudva YC, Laffel LM, Levy CJ, Pinsker JE, Wadwa RP, Dassau E, Doyle FJ 3rd, Anderson SM, Church MM, Dadlani V, Ekhlaspour L, Forlenza GP, Isganaitis E, Lam DW, Kollman C, Beck RW; iDCL Trial Research Group.

N Engl J Med. 2019 Oct 31;381(18):1707-1717. doi: 10.1056/NEJMoa1907863. Epub 2019 Oct 16.

PMID:
31618560
4.

Association of metformin and statin medications with surrogate measures of cardiovascular disease in youth with type 1 diabetes: the SEARCH for diabetes in youth study.

Gourgari E, Stafford JM, D'Agostino R Jr, Dolan LM, Lawrence JM, Mottl A, Pihoker C, Urbina EM, Wadwa RP, Dabelea D.

Ann Pediatr Endocrinol Metab. 2019 Sep;24(3):187-194. doi: 10.6065/apem.2019.24.3.187. Epub 2019 Sep 30.

5.

Safety and Performance of the Omnipod Hybrid Closed-Loop System in Adults, Adolescents, and Children with Type 1 Diabetes Over 5 Days Under Free-Living Conditions.

Sherr JL, Buckingham BA, Forlenza GP, Galderisi A, Ekhlaspour L, Wadwa RP, Carria L, Hsu L, Berget C, Peyser TA, Lee JB, O'Connor J, Dumais B, Huyett LM, Layne JE, Ly TT.

Diabetes Technol Ther. 2019 Oct 29. doi: 10.1089/dia.2019.0286. [Epub ahead of print]

PMID:
31596130
6.

Elevated copeptin, arterial stiffness, and elevated albumin excretion in adolescents with type 1 diabetes.

Wiromrat P, Bjornstad P, Vinovskis C, Chung LT, Roncal C, Pyle L, Lanaspa MA, Johnson RJ, Cherney DZ, Reznick-Lipina TK, Bishop F, Maahs DM, Wadwa RP.

Pediatr Diabetes. 2019 Dec;20(8):1110-1117. doi: 10.1111/pedi.12909. Epub 2019 Aug 29.

PMID:
31433534
7.

Serum uromodulin is associated with urinary albumin excretion in adolescents with type 1 diabetes.

Wiromrat P, Bjornstad P, Roncal C, Pyle L, Johnson RJ, Cherney DZ, Lipina T, Bishop F, Maahs DM, Wadwa RP.

J Diabetes Complications. 2019 Sep;33(9):648-650. doi: 10.1016/j.jdiacomp.2019.05.023. Epub 2019 Jun 3.

PMID:
31253490
8.

Burden of Cardiovascular Risk Factors Over Time and Arterial Stiffness in Youth With Type 1 Diabetes Mellitus: The SEARCH for Diabetes in Youth Study.

Urbina EM, Isom S, Bell RA, Bowlby DA, D'Agostino R Jr, Daniels SR, Dolan LM, Imperatore G, Marcovina SM, Merchant AT, Reynolds K, Shah AS, Wadwa RP, Dabelea D; SEARCH for Diabetes in Youth Study Group.

J Am Heart Assoc. 2019 Jul 2;8(13):e010150. doi: 10.1161/JAHA.118.010150. Epub 2019 Jun 19.

9.

Closed loop control in adolescents and children during winter sports: Use of the Tandem Control-IQ AP system.

Ekhlaspour L, Forlenza GP, Chernavvsky D, Maahs DM, Wadwa RP, Deboer MD, Messer LH, Town M, Pinnata J, Kruse G, Kovatchev BP, Buckingham BA, Breton MD.

Pediatr Diabetes. 2019 Sep;20(6):759-768. doi: 10.1111/pedi.12867. Epub 2019 May 23.

10.

Performance of Omnipod Personalized Model Predictive Control Algorithm with Moderate Intensity Exercise in Adults with Type 1 Diabetes.

Forlenza GP, Buckingham BA, Christiansen MP, Wadwa RP, Peyser TA, Lee JB, O'Connor J, Dassau E, Huyett LM, Layne JE, Ly TT.

Diabetes Technol Ther. 2019 May;21(5):265-272. doi: 10.1089/dia.2019.0017. Epub 2019 Mar 29.

11.

Successful At-Home Use of the Tandem Control-IQ Artificial Pancreas System in Young Children During a Randomized Controlled Trial.

Forlenza GP, Ekhlaspour L, Breton M, Maahs DM, Wadwa RP, DeBoer M, Messer LH, Town M, Pinnata J, Kruse G, Buckingham BA, Cherñavvsky D.

Diabetes Technol Ther. 2019 Apr;21(4):159-169. doi: 10.1089/dia.2019.0011. Epub 2019 Mar 19.

PMID:
30888835
12.

A Clinical Training Program for Hybrid Closed Loop Therapy in a Pediatric Diabetes Clinic.

Berget C, Thomas SE, Messer LH, Thivener K, Slover RH, Wadwa RP, Alonso GT.

J Diabetes Sci Technol. 2019 Mar 12:1932296819835183. doi: 10.1177/1932296819835183. [Epub ahead of print]

PMID:
30862242
13.

Factory-Calibrated Continuous Glucose Monitoring: How and Why It Works, and the Dangers of Reuse Beyond Approved Duration of Wear.

Forlenza GP, Kushner T, Messer LH, Wadwa RP, Sankaranarayanan S.

Diabetes Technol Ther. 2019 Apr;21(4):222-229. doi: 10.1089/dia.2018.0401. Epub 2019 Feb 28.

PMID:
30817171
14.

Malglycemia is associated with poor outcomes in pediatric and adolescent hematopoietic stem cell transplant patients.

Sopfe J, Pyle L, Keating AK, Campbell K, Liu AK, Wadwa RP, Verneris MR, Giller RH, Forlenza GP.

Blood Adv. 2019 Feb 12;3(3):350-359. doi: 10.1182/bloodadvances.2018021014.

15.

The International Diabetes Closed-Loop Study: Testing Artificial Pancreas Component Interoperability.

Anderson SM, Dassau E, Raghinaru D, Lum J, Brown SA, Pinsker JE, Church MM, Levy C, Lam D, Kudva YC, Buckingham B, Forlenza GP, Wadwa RP, Laffel L, Doyle FJ 3rd, DeVries JH, Renard E, Cobelli C, Boscari F, Del Favero S, Kovatchev BP.

Diabetes Technol Ther. 2019 Feb;21(2):73-80. doi: 10.1089/dia.2018.0308. Epub 2019 Jan 16.

PMID:
30649925
16.

Metformin Improves Insulin Sensitivity and Vascular Health in Youth With Type 1 Diabetes Mellitus.

Bjornstad P, Schäfer M, Truong U, Cree-Green M, Pyle L, Baumgartner A, Garcia Reyes Y, Maniatis A, Nayak S, Wadwa RP, Browne LP, Reusch JEB, Nadeau KJ.

Circulation. 2018 Dec 18;138(25):2895-2907. doi: 10.1161/CIRCULATIONAHA.118.035525.

PMID:
30566007
17.

Biopsychosocial Factors Associated With Satisfaction and Sustained Use of Artificial Pancreas Technology and Its Components: a Call to the Technology Field.

Forlenza GP, Messer LH, Berget C, Wadwa RP, Driscoll KA.

Curr Diab Rep. 2018 Sep 26;18(11):114. doi: 10.1007/s11892-018-1078-1. Review.

18.

Inflammation, adiposity, and progression of arterial stiffness in adolescents with type 1 diabetes: The SEARCH CVD Study.

Alman AC, Talton JW, Wadwa RP, Urbina EM, Dolan LM, Hamman RF, D'Agostino RB Jr, Marcovina SM, Dabelea DM.

J Diabetes Complications. 2018 Nov;32(11):995-999. doi: 10.1016/j.jdiacomp.2018.08.004. Epub 2018 Aug 9.

19.

Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children With Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial.

Forlenza GP, Li Z, Buckingham BA, Pinsker JE, Cengiz E, Wadwa RP, Ekhlaspour L, Church MM, Weinzimer SA, Jost E, Marcal T, Andre C, Carria L, Swanson V, Lum JW, Kollman C, Woodall W, Beck RW.

Diabetes Care. 2018 Oct;41(10):2155-2161. doi: 10.2337/dc18-0771. Epub 2018 Aug 8.

PMID:
30089663
20.

ISPAD Clinical Practice Consensus Guidelines 2018: Microvascular and macrovascular complications in children and adolescents.

Donaghue KC, Marcovecchio ML, Wadwa RP, Chew EY, Wong TY, Calliari LE, Zabeen B, Salem MA, Craig ME.

Pediatr Diabetes. 2018 Oct;19 Suppl 27:262-274. doi: 10.1111/pedi.12742. No abstract available.

PMID:
30079595
21.

Performance of the Omnipod Personalized Model Predictive Control Algorithm with Meal Bolus Challenges in Adults with Type 1 Diabetes.

Buckingham BA, Christiansen MP, Forlenza GP, Wadwa RP, Peyser TA, Lee JB, O'Connor J, Dassau E, Huyett LM, Layne JE, Ly TT.

Diabetes Technol Ther. 2018 Sep;20(9):585-595. doi: 10.1089/dia.2018.0138. Epub 2018 Aug 2.

22.

Lower objectively measured physical activity is linked with perceived risk of hypoglycemia in type 1 diabetes.

Keshawarz A, Piropato AR, Brown TL, Duca LM, Sippl RM, Wadwa RP, Snell-Bergeon JK.

J Diabetes Complications. 2018 Nov;32(11):975-981. doi: 10.1016/j.jdiacomp.2018.05.020. Epub 2018 Jun 2.

PMID:
29937138
23.

Performance of a Factory-Calibrated Real-Time Continuous Glucose Monitoring System Utilizing an Automated Sensor Applicator.

Shah VN, Laffel LM, Wadwa RP, Garg SK.

Diabetes Technol Ther. 2018 Jun;20(6):428-433. doi: 10.1089/dia.2018.0143.

24.

Accuracy of a Factory-Calibrated, Real-Time Continuous Glucose Monitoring System During 10 Days of Use in Youth and Adults with Diabetes.

Wadwa RP, Laffel LM, Shah VN, Garg SK.

Diabetes Technol Ther. 2018 Jun;20(6):395-402. doi: 10.1089/dia.2018.0150. Epub 2018 Jun 14.

25.

Fully Closed-Loop Multiple Model Probabilistic Predictive Controller Artificial Pancreas Performance in Adolescents and Adults in a Supervised Hotel Setting.

Forlenza GP, Cameron FM, Ly TT, Lam D, Howsmon DP, Baysal N, Kulina G, Messer L, Clinton P, Levister C, Patek SD, Levy CJ, Wadwa RP, Maahs DM, Bequette BW, Buckingham BA.

Diabetes Technol Ther. 2018 May;20(5):335-343. doi: 10.1089/dia.2017.0424. Epub 2018 Apr 16.

26.

Optimizing Hybrid Closed-Loop Therapy in Adolescents and Emerging Adults Using the MiniMed 670G System.

Messer LH, Forlenza GP, Sherr JL, Wadwa RP, Buckingham BA, Weinzimer SA, Maahs DM, Slover RH.

Diabetes Care. 2018 Apr;41(4):789-796. doi: 10.2337/dc17-1682. Epub 2018 Feb 14.

27.

Safety and Feasibility of the OmniPod Hybrid Closed-Loop System in Adult, Adolescent, and Pediatric Patients with Type 1 Diabetes Using a Personalized Model Predictive Control Algorithm.

Buckingham BA, Forlenza GP, Pinsker JE, Christiansen MP, Wadwa RP, Schneider J, Peyser TA, Dassau E, Lee JB, O'Connor J, Layne JE, Ly TT.

Diabetes Technol Ther. 2018 Apr;20(4):257-262. doi: 10.1089/dia.2017.0346. Epub 2018 Feb 12.

28.

Closed-Loop Control During Intense Prolonged Outdoor Exercise in Adolescents With Type 1 Diabetes: The Artificial Pancreas Ski Study.

Breton MD, Cherñavvsky DR, Forlenza GP, DeBoer MD, Robic J, Wadwa RP, Messer LH, Kovatchev BP, Maahs DM.

Diabetes Care. 2017 Dec;40(12):1644-1650. doi: 10.2337/dc17-0883. Epub 2017 Aug 30.

29.

The dawn of automated insulin delivery: A new clinical framework to conceptualize insulin administration.

Messer LH, Forlenza GP, Wadwa RP, Weinzimer SA, Sherr JL, Hood KK, Buckingham BA, Slover RH, Maahs DM.

Pediatr Diabetes. 2018 Feb;19(1):14-17. doi: 10.1111/pedi.12535. Epub 2017 Jun 27. No abstract available.

PMID:
28656656
30.

PCSK9 Is Increased in Youth With Type 1 Diabetes.

Levenson AE, Wadwa RP, Shah AS, Khoury PR, Kimball TR, Urbina EM, de Ferranti SD, Bishop FK, Maahs DM, Dolan LM, Biddinger SB.

Diabetes Care. 2017 Jul;40(7):e85-e87. doi: 10.2337/dc16-2563. Epub 2017 Jun 6. No abstract available.

31.

Outpatient Closed-Loop Control with Unannounced Moderate Exercise in Adolescents Using Zone Model Predictive Control.

Huyett LM, Ly TT, Forlenza GP, Reuschel-DiVirgilio S, Messer LH, Wadwa RP, Gondhalekar R, Doyle FJ 3rd, Pinsker JE, Maahs DM, Buckingham BA, Dassau E.

Diabetes Technol Ther. 2017 Jun;19(6):331-339. doi: 10.1089/dia.2016.0399. Epub 2017 May 1.

32.

Obesity and type 2 diabetes are associated with elevated PCSK9 levels in young women.

Levenson AE, Shah AS, Khoury PR, Kimball TR, Urbina EM, de Ferranti SD, Maahs DM, Dolan LM, Wadwa RP, Biddinger SB.

Pediatr Diabetes. 2017 Dec;18(8):755-760. doi: 10.1111/pedi.12490. Epub 2017 Jan 17.

33.

Response to Comment on Rickels et al. Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study. Diabetes Care 2016;39:264-270.

Rickels MR, Ruedy KJ, Foster NC, Piché CA, Dulude H, Sherr JL, Tamborlane WV, Bethin KE, DiMeglio LA, Wadwa RP, Ahmann AJ, Haller MJ, Nathan BM, Marcovina SM, Rampakakis E, Meng L, Beck RW; T1D Exchange Intranasal Glucagon Investigators.

Diabetes Care. 2016 Oct;39(10):e193-4. doi: 10.2337/dci16-0025. No abstract available.

34.

Ketone production in children with type 1 diabetes, ages 4-14 years, with and without nocturnal insulin pump suspension.

Wadwa RP, Chase HP, Raghinaru D, Buckingham BA, Hramiak I, Maahs DM, Messer L, Ly T, Aye T, Clinton P, Kollman C, Beck RW, Lum J; In Home Closed Loop Study Group.

Pediatr Diabetes. 2017 Sep;18(6):422-427. doi: 10.1111/pedi.12410. Epub 2016 Jul 12.

35.

Duration of Infusion Set Survival in Lipohypertrophy Versus Nonlipohypertrophied Tissue in Patients with Type 1 Diabetes.

Karlin AW, Ly TT, Pyle L, Forlenza GP, Messer L, Wadwa RP, DeSalvo DJ, Payne SL, Hanes S, Clinton P, Maahs DM, Buckingham B.

Diabetes Technol Ther. 2016 Jul;18(7):429-35. doi: 10.1089/dia.2015.0432. Epub 2016 May 26.

36.

Continuous Glucose Sensor Survival and Accuracy Over 14 Consecutive Days.

DeSalvo DJ, Ly TT, Wadwa RP, Messer L, Westfall E, Gopisetty D, Hanes S, von Eyben R, Maahs DM, Buckingham BA.

Diabetes Care. 2016 Aug;39(8):e112-3. doi: 10.2337/dc16-0796. Epub 2016 May 23. No abstract available.

37.

Influences of gender on cardiovascular disease risk factors in adolescents with and without type 1 diabetes.

Brown TL, Maahs DM, Bishop FK, Snell-Bergeon JK, Wadwa RP.

Int J Pediatr Endocrinol. 2016;2016:8. doi: 10.1186/s13633-016-0026-6. Epub 2016 Apr 19.

38.

Reduced brachial artery distensibility in patients with type 1 diabetes.

Ljunggren P, Maahs DM, Johansson P, Ludvigsson J, Pyle L, Sippl R, Wadwa RP, Snell-Bergeon J.

J Diabetes Complications. 2016 Jul;30(5):893-7. doi: 10.1016/j.jdiacomp.2016.03.004. Epub 2016 Mar 11.

39.

Glucagon Nasal Powder: A Promising Alternative to Intramuscular Glucagon in Youth With Type 1 Diabetes.

Sherr JL, Ruedy KJ, Foster NC, Piché CA, Dulude H, Rickels MR, Tamborlane WV, Bethin KE, DiMeglio LA, Fox LA, Wadwa RP, Schatz DA, Nathan BM, Marcovina SM, Rampakakis E, Meng L, Beck RW; T1D Exchange Intranasal Glucagon Investigators.

Diabetes Care. 2016 Apr;39(4):555-62. doi: 10.2337/dc15-1606. Epub 2016 Feb 16.

40.

Predictors of Increased Carotid Intima-Media Thickness in Youth With Type 1 Diabetes: The SEARCH CVD Study.

Shah AS, Dabelea D, Fino NF, Dolan LM, Wadwa RP, D'Agostino R Jr, Hamman R, Marcovina S, Daniels SR, Urbina EM.

Diabetes Care. 2016 Mar;39(3):418-25. doi: 10.2337/dc15-1963. Epub 2015 Dec 30.

41.

Hyperfiltration and uricosuria in adolescents with type 1 diabetes.

Bjornstad P, Roncal C, Milagres T, Pyle L, Lanaspa MA, Bishop FK, Snell-Bergeon JK, Johnson RJ, Wadwa RP, Maahs DM.

Pediatr Nephrol. 2016 May;31(5):787-93. doi: 10.1007/s00467-015-3299-8. Epub 2015 Dec 23.

42.

Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study.

Rickels MR, Ruedy KJ, Foster NC, Piché CA, Dulude H, Sherr JL, Tamborlane WV, Bethin KE, DiMeglio LA, Wadwa RP, Ahmann AJ, Haller MJ, Nathan BM, Marcovina SM, Rampakakis E, Meng L, Beck RW; T1D Exchange Intranasal Glucagon Investigators.

Diabetes Care. 2016 Feb;39(2):264-70. doi: 10.2337/dc15-1498. Epub 2015 Dec 17.

43.

Periodontal Microorganisms and Cardiovascular Risk Markers in Youth With Type 1 Diabetes and Without Diabetes.

Merchant AT, Nahhas GJ, Wadwa RP, Zhang J, Tang Y, Johnson LR, Maahs DM, Bishop F, Teles R, Morrato EH.

J Periodontol. 2016 Apr;87(4):376-84. doi: 10.1902/jop.2015.150531. Epub 2015 Nov 28.

PMID:
26616842
44.

Effect of lipohypertrophy on accuracy of continuous glucose monitoring in patients with type 1 diabetes.

DeSalvo DJ, Maahs DM, Messer L, Wadwa RP, Payne S, Ly TT, Buckingham BA.

Diabetes Care. 2015 Oct;38(10):e166-7. doi: 10.2337/dc15-1267. Epub 2015 Aug 25. No abstract available.

45.

Use of Telemedicine to Improve Adherence to American Diabetes Association Standards in Pediatric Type 1 Diabetes.

Wood CL, Clements SA, McFann K, Slover R, Thomas JF, Wadwa RP.

Diabetes Technol Ther. 2016 Jan;18(1):7-14. doi: 10.1089/dia.2015.0123. Epub 2015 Aug 21.

PMID:
26295939
46.

Erratum. Predictive Low-Glucose Insulin Suspension Reduces Duration of Nocturnal Hypoglycemia in Children Without Increasing Ketosis. Diabetes Care 2015;38:1197-1204.

Buckingham BA, Raghinaru D, Cameron F, Bequette BW, Chase HP, Maahs DM, Slover R, Wadwa RP, Wilson DM, Ly T, Aye T, Hramiak I, Clarson C, Stein R, Gallego PH, Lum J, Sibayan J, Kollman C, Beck RW; In Home Closed Loop Study Group.

Diabetes Care. 2015 Sep;38(9):1813. doi: 10.2337/dc15-er09. No abstract available.

47.

Effect of acetaminophen on CGM glucose in an outpatient setting.

Maahs DM, DeSalvo D, Pyle L, Ly T, Messer L, Clinton P, Westfall E, Wadwa RP, Buckingham B.

Diabetes Care. 2015 Oct;38(10):e158-9. doi: 10.2337/dc15-1096. Epub 2015 Aug 12. No abstract available.

48.

Predictive Low-Glucose Insulin Suspension Reduces Duration of Nocturnal Hypoglycemia in Children Without Increasing Ketosis.

Buckingham BA, Raghinaru D, Cameron F, Bequette BW, Chase HP, Maahs DM, Slover R, Wadwa RP, Wilson DM, Ly T, Aye T, Hramiak I, Clarson C, Stein R, Gallego PH, Lum J, Sibayan J, Kollman C, Beck RW; In Home Closed Loop Study Group.

Diabetes Care. 2015 Jul;38(7):1197-204. doi: 10.2337/dc14-3053. Epub 2015 Jun 6. Erratum in: Diabetes Care. 2015 Sep;38(9):1813.

49.

Arterial stiffness in adolescents and young adults with and without type 1 diabetes: the SEARCH CVD study.

Shah AS, Wadwa RP, Dabelea D, Hamman RF, D'Agostino R Jr, Marcovina S, Daniels SR, Dolan LM, Fino NF, Urbina EM.

Pediatr Diabetes. 2015 Aug;16(5):367-74. doi: 10.1111/pedi.12279. Epub 2015 Apr 24.

50.

Insulin sensitivity and arterial stiffness in youth with type 1 diabetes: the SEARCH CVD study.

Shah AS, Black S, Wadwa RP, Schmiege SJ, Fino NF, Talton JW, D'Agostino R Jr, Hamman RF, Urbina EM, Dolan LM, Daniels SR, Marcovina SM, Dabelea D.

J Diabetes Complications. 2015 May-Jun;29(4):512-6. doi: 10.1016/j.jdiacomp.2015.02.004. Epub 2015 Feb 14.

Supplemental Content

Loading ...
Support Center